Balaxi Pharmaceuticals

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue19.8822.4514.089.9717.17
Expenses17.9820.2411.7411.1016.91
EBITDA2.362.773.01-0.331.00
EBIT2.242.652.90-0.450.89
Profit Before Tax1.892.202.33-1.140.25
Net Profit1.381.661.74-1.180.19
Financial Ratios
Operating Profit Margin12.40%13.09%26.97%-3.42%5.98%
Net Profit Margin7.25%7.84%15.59%-12.23%1.14%
Earning Per Share (Diluted)0.250.300.32-0.210.04
Dividends Per Share0.000.000.000.000.00